All stories tagged :

Sample Category Title

AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across...

admin
Pr Newswire

GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s...

admin
Economy

Infocom Receives Prestigious Honor at 2024 Asia-Pacific Stevie Awards

admin
Economy

Saia Opens New Terminal in Laredo, Texas

admin
Economy

GBCI 2024: Turkey remains the most complex Middle Eastern country in...

admin
Pr Newswire

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR...

admin
Economy

President Lula to Speak at FII PRIORITY Rio de Janeiro Summit...

admin
Pr Newswire

Leading Indonesian digital bank, Jenius chooses Perx to transform its customer...

admin
Economy

New AI agent for venture capital: 100x cheaper, 5x faster and...

admin
Economy

Global Cystatin C Assay Market Size To Worth USD 525.9 Million...

admin
Pr Newswire

ProKidney Announces Proposed $125 Million Public Offering of Class A Ordinary...

admin

Featured

Pr Newswire

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

admin
Pr Newswire

Virtual IT Group and The Instillery Go to Town on Zero...

admin
Pr Newswire

HKUST Deepens Sweden Ties Positioning Hong Kong as a Strategic Nexus...

admin
Pr Newswire

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for...

admin
admin

Real-World Evidence of NEFECON® to Be Presented in Seven New Abstracts...

7 new NEFECON® real-world evidence abstracts will be presented at the 18th International lgA Nephropathy Symposium (IIgANN 2025). The newly released results, based on clinical practices at several leading hospitals in China, offer a comprehensive overview of the efficacy and safety of NEFECON® in the treatment of IgA...